Dr Sedona Sweeney
in Health Economics
15-17 Tavistock Place
Sedona has nine years’ experience in economic evaluation in low- and middle-income countries. Her research focuses on the improving understanding of the economic impact of substantial long-term health shocks, both at the provider level and within the household. Her research to date has been focused on measurement and understanding of the costs of chronic illness – including HIV, TB, chronic non-communicable diseases, and HCV.
She is a member of the Task Force on Catastrophic Cost Measurement for TB, and is a co-investigator of the Value-TB project; a Bill and Melinda Gates funded multi-country costing study of TB interventions. She is also involved with the Global Health Costing Consortium, in which she focuses on costing standards and methods.
Sedona teaches on the Economic Evaluation module for in-house students. She also supervises HPPF students.
Sedona's current research projects include:
- VALUE-TB: a collaboration between LSHTM, University of Cape Town, and WHO aiming to collect cost data to facilitate decision-making for TB in five countries (incl. Kenya, Ethiopia, Philippines, India, and Russia)
- the Global Health Cost Consortium: which aims to mitigate the TB and HIV epidemics by systematically improving the availability, quality, timing, relevance, interpretation, and use of cost information on HIV and tuberculosis (TB) programs and services
- the Integra Initiative: an analysis of integrated HIV and sexual and reproductive health services in Kenya and Swaziland
- the Health Systems Chronic Disease project: a project aiming to improve the health systems response to chronic disease in Uganda and Tanzania
- a project assessing the impact and cost-effectiveness of needle/syringe provision on hepatitis C transmission among people who inject drugs in the UK
- the MERGE project: evaluating a model of scaling-up integrated TB and HIV services in South Africa